Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  gadobutrol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
Phase: Phase IV
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91780, 2007-005693-31, 312021, NCT00764387
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91569, 310864, NCT00522951
Gadobutrol Magnevist-controlled Body Study
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13297, NCT01050829
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91743, GEMMA 1, 2009-009597-27, NCT01067976
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 91782, 2009-009598-90, NCT01104584
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
Phase: No phase specified
Type: Diagnostic
Status: Enrolling by invitation
Age: 19 and over
Sponsor: Other
Protocol IDs: 585-13, NCT02095353
Start Over